Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Mouth Neoplasms 1Liver Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma in Situ 1

Interventions

Biopsy 4Surgical Procedures, Operative 3Cisplatin 3Cetuximab 3Radiotherapy 2Fluorouracil 2Cyclophosphamide 2Celecoxib 2tozuleristide 1temsirolimus 1antineoplaston AS 2-1 1antineoplaston A10 1advexin 1Valproic Acid 1Thalidomide 1Sirolimus 1Observation 1Metformin 1Immunohistochemistry 1Immunoglobulin G 1Fluorescent Antibody Technique 1Flow Cytometry 1Fenretinide 1Everolimus 1Etoposide 1Electroacupuncture 1Docetaxel 1Disulfides 1Dihematoporphyrin Ether 1Diagnosis, Oral 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Mouth Neoplasms × advexin × Clear all
NCT00410865 2011-12-07

Wild Type p53 Adenovirus for Oral Premalignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled
Head & Neck

Carcinoma in Situ, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡